• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Model Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Date 07/13/2016
Event Type  Injury  
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the physician used the venaseal to treat the short saphenous vein as per ifu.The patient was treated for a stasis ulcer that was contaminated but not infected (no cellulitis) at the time of procedure ((b)(6) 2016).The procedure was completed with no issue noted.It was reported the patient suffered infection post procedure which extended about 6-7 cm from the puncture site and included a tributary vein that also had infected glue.The skin over the tributary vein and surrounding subcutaneous tissues essentially formed an abscess that spontaneously drained.Small plugs of glue and pus came out at the "satellite" site.Patient was treated with oral antibiotics.The physician eventually had to surgically excise the infected vein under general anaesthesia ((b)(6) 2016), by carrying out a left leg incision, draining of skin and subcutaneous tissue and excision of vessels of lower limb veins.There was a small amount of purulent material around glue in distal segment of short saphenous vein tributary at site of satellite infection (cultured); short saphenous vein contained glue that did appear infected.Cultures from the excised vein where tested the results showed the glue grew pseudomonas.The patient is responding to oral cipro, clindamycin 300 mg x 10 days and open wound care.The patient is reported as stable with the wounds healing slowly.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
COVIDIEN
951 aviation parkway
morrisville NC 27560 6228
Manufacturer (Section G)
COVIDIEN
951 aviation parkway
morrisville NC 27560 6228
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6181145
MDR Text Key62593163
Report Number2183870-2016-00723
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 11/28/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberVS-402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/28/2016
Initial Date FDA Received12/16/2016
Supplement Dates Manufacturer Received11/28/2016
Supplement Dates FDA Received09/28/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-